Patents by Inventor Michael R. Shurin

Michael R. Shurin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220365078
    Abstract: A method of detecting an analyte in a fluid sample includes exposing a sensor including a substrate and a sensor medium on the substrate to the fluid sample for a period of time. The sensor medium includes a plurality of nanostructures and one or more of at least one agent selected from the group consisting of an antibody, an antigen receptor or an antigen immobilized upon at least a portion of the plurality of nanostructures. The at least one agent is an antibody or an antigen receptor if the analyte is an antigen and is an antigen if the analyte is an antibody. An electrolyte liquid having a known ionic strength which is less than the fluid sample is added over the sensor medium subsequent to exposing the sensor to the fluid and a variable providing a measure of change in at least one property of the sensor medium which is dependent upon the presence of the analyte is measured in presence of the electrolyte liquid.
    Type: Application
    Filed: May 9, 2022
    Publication date: November 17, 2022
    Inventors: Alexander Star, Michael R. Shurin, Sarah Elizabeth Wheeler, Wenting Shao
  • Publication number: 20220187309
    Abstract: Disclosed herein are compositions and uses thereof for detection of disease-related antibodies. The methods include contacting a biological sample with a solid support comprising one or more antigens that bind one or more therapeutic monoclonal antibodies, and detecting the disease-related antibody in the biological sample using an electrophoretic method.
    Type: Application
    Filed: April 29, 2020
    Publication date: June 16, 2022
    Inventors: Sarah E. WHEELER, Michael R. SHURIN, Li LIU
  • Publication number: 20080187511
    Abstract: The invention provides an oil-based pharmaceutical composition comprising as an active ingredient phostphatidylserine or a derivative thereof and a pharmaceutically acceptable oil-based carrier, which is formulated for topical or intratumoral administration. Preferably, the composition is an ointment or a cream. The composition can contain additional active agents as well, such as aminophospholipid translocase inhibitors, transnitrosylating agents, chemokines, cytokines, Toll-like receptor ligands, imidazoquinolines, dendritic cell differentiation factors, or combinations thereof. In another aspect, the invention provides a method of treating cancer within a patient in need of treatment by administering the inventive composition to the patient.
    Type: Application
    Filed: October 25, 2007
    Publication date: August 7, 2008
    Applicants: System of Higher Education
    Inventors: Michael R. Shurin, Valerian E. Kagan, Galina V. Shurin, Yulia Tyurina